COSCIENS Biopharma Completes Share Capital Amendment
COSCIENS Biopharma's (CSCI.TO) one for 150 share consolidation and a following share split took effect on Friday.COSCIENS said it competed the share consolidation and an immediate subsequent split of shares on the basis of 50 shares for every one post-consolidation share.Shareholders who held less than 150 shares as of the close of business on Thursday are entitled to a cash payment of US$1.60 in exchange for their pre-consolidation shares, the company said.COSCIENS said the shares are expected to begin trading on the Toronto Stock Exchange on a post-share capital amendment basis within two business days of the effective date under the same trading symbol.COSCIENS subsidiary Ceapro is focused on developing f natural, plant-based ingredients derived from oats and other renewable plant resources for personal care, cosmetic, human and animal health industries.
